• Mashup Score: 2
    Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma | NEJM - 3 year(s) ago

    Original Article from The New England Journal of Medicine — Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

    Source: New England Journal of Medicine
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma [Feb 25, 2021] Munshi @ldandersonjr @ninashah33 @DMadduri @BerdejaJesus @SagarLonialMD @NoopurRajeMD @YiLinMDPhD Siegel et al. San-Miguel @NEJM https://t.co/niEWhCr4Y5 #NCT03361748 #mmsm #CARTcell https://t.co/UgF4UPBrAL

    • Profile photo of mtmdphd
      mtmdphd

      Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma [Feb 25, 2021] Munshi @ldandersonjr @ninashah33 @DMadduri @BerdejaJesus @SagarLonialMD @NoopurRajeMD @YiLinMDPhD @DavidSiegel et al. San-Miguel @NEJM https://t.co/niEWhCr4Y5 #NCT03361748 #mmsm #CARTcell https://t.co/jkKIYSqQVF